151 studies found for:    "Gout"
Show Display Options
Rank Status Study
21 Recruiting Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
Conditions: Gout;   Chronic Kidney Diseases
Interventions: Drug: Anakinra 100mg and Placebo Depo-Medrone;   Drug: Depo-Medrone 120mg and Placebo (Anakinra)
22 Completed A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
Conditions: Gout;   Hyperuricemia;   Arthritis;   Joint Disease;   Renal Insufficiency
Interventions: Drug: Placebo;   Drug: Ulodesine (BCX4208) 5 mg;   Drug: Ulodesine (BCX4208) 10 mg
23 Completed
Has Results
Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol;   Drug: Placebo
24 Completed Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: Allopurinol;   Drug: BCX4208
25 Completed
Has Results
A Proof-of-Concept Study of AC-201 to Prevent Gout Flares
Condition: Gout Flares
Interventions: Drug: Placebo;   Drug: AC-201;   Drug: Febuxostat
26 Completed Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
Condition: Recurrent or Tophaceous Gout
Interventions: Other: Control;   Other: Gout Disease Management Program
27 Completed Study Utilizing Rilonacept in Gout Exacerbations
Condition: Acute Gout Flare
Interventions: Drug: rilonacept;   Drug: indomethacin;   Other: placebo
28 Completed
Has Results
Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
Condition: Chronic Gout Refractory to Conventional Therapy
Intervention: Drug: pegloticase 8 mg i.v.
29 Completed
Has Results
Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients
Condition: Acute Gout
Interventions: Drug: Canakinumab;   Drug: Triamcinolone acetonide
30 Completed PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
Condition: Intercritical Gout
Intervention: Drug: rilonacept
31 Completed
Has Results
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.
Condition: Acute Gout
Interventions: Drug: Canakinumab 150 mg;   Drug: Triamcinolone acetonide 40 mg;   Drug: Placebo to canakinumab;   Drug: Placebo to triamcinolone acetonide
32 Completed
Has Results
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study
Condition: Acute Gout
Interventions: Drug: Canakinumab 150 mg;   Drug: Triamcinolone acetonide 40 mg;   Drug: Placebo to canakinumab;   Drug: Placebo to triamcinolone acetonide
33 Completed Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Conditions: Moderate to Severe Gout;   Hyperuricemia
Interventions: Drug: Combination 400;   Drug: Allopurinol;   Drug: Combination 600
34 Active, not recruiting Arthritis Research UK Gout Treatment Trial - Phase 2
Condition: Gout
Interventions: Other: Nurse intervention;   Other: Standard care
35 Completed
Has Results
Long-Term Safety of Febuxostat in Subjects With Gout.
Condition: Gout
Intervention: Drug: Febuxostat
36 Not yet recruiting SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO 2 Study
Conditions: Gout;   Low Medication Adherence;   Health Related Quality of Life
Intervention: Behavioral: Improvement of Medication Adherence
37 Completed
Has Results
Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: Febuxostat
38 Recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
39 Completed RDEA3170 Monotherapy in Subjects With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: RDEA3170 5 mg;   Drug: RDEA3170 10 mg;   Drug: RDEA3170 12.5 mg
40 Recruiting DECT Study in Allopurinol-Treated Gout Patients
Condition: Gout
Intervention: Procedure: DECT scan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years